A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A

This publication has 89 references indexed in Scilit:

• Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
  Vaccine, 2008
• Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile -Induced Mortality in Hamsters
  Infection and Immunity, 2006
• LEISHMANIA MAJOR SOLUBLE EXO-ANTIGENS (LmSEAgs) PROTECT NEONATAL BALB/C MICE FROM A SUBSEQUENT CHALLENGE WITH L. MAJOR AND STIMULATE CYTOKINE PRODUCTION BY LEISHMANIA-NAÏVE HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
  Journal of Parasitology, 2006
• Clostridium difficileToxins: Mechanism of Action and Role in Disease
  Clinical Microbiology Reviews, 2005
• Active and passive immunization against Clostridium difficile diarrhea and colitis
  Vaccine, 2003
• Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A
  Infection and Immunity, 2003
• Electroporation improves the efficacy of DNA vaccines in large animals
  Vaccine, 2002
• The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies
  Vaccine, 1996
• Vaccination against lethalClostridium difficile enterocolitis with a nontoxic recombinant peptide of toxin A
  Current Microbiology, 1990
• Nosocomial Acquisition ofClostridium difficileInfection
  New England Journal of Medicine, 1989